Robert J.C. Slebos

K-<i>ras</i>Oncogene Activation as a Prognostic Marker in Adenocarcinoma of the Lung

Robert J.C. Slebos, R.E. Kibbelaar, Otilia Dalesio et al. · New England Journal of Medicine · 1990 · 811 citations · Full text

Medicine, Molecular Genetics, Oncology +16

Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage.

Theodore D. Kessis, Robert J.C. Slebos, William G. Nelson et al. · Proceedings of the National Academy of Sciences · 1993 · 530 citations · Full text

Medicine, Molecular Biology, Oncology +17

Clinical significance of ras oncogene activation in human lung cancer

Sjoerd Rodenhuis, Robert J.C. Slebos · Lung Cancer · 1993 · 365 citations

Medicine, Genetics, Oncology +16

p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein.

Robert J.C. Slebos, M H Lee, Beverly Plunkett et al. · Proceedings of the National Academy of Sciences · 1994 · 346 citations

Life Sciences, Molecular Biology, Oncology +17

K-ras oncogene activation in atypical alveolar hyperplasias of the human lung.

William H. Westra, Inge O. Baas, R.H. Hruban et al. · PubMed · 1996 · 224 citations

Medicine, Genetics, Oncology +17